Illumina Inc (NASDAQ:ILMN)
CAPS Rating:
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
Recs
Overvalued in this funding environment. And all the value in complex diagnostics is being gobbled up by labs not hardware companies.